Alector Announces Positive Results from AL002 INVOKE-2 Phase 2 Trial for Early Alzheimer’s Disease and Business Update

SOUTH SAN FRANCISCO, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC) AL002 Clinical Trial Results Introduction Alector, Inc., a clinical-stage biotechnology company focusing on novel therapies for neurodegenerative diseases, recently released results from the INVOKE-2 Phase 2 clinical trial evaluating the safety and efficacy of AL002 in early Alzheimer’s disease (AD) patients….

Read More

Regn Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation into Potential Securities Law Violations – Here’s What It Means for You

Bronstein, Gewirtz & Grossman, LLC: A Class Action Lawsuit Against Regeneron Pharmaceuticals, Inc. In the bustling heart of New York City, among the towering skyscrapers and bustling streets, a significant legal development unfolded. On February 23, 2025, Bronstein, Gewirtz & Grossman, LLC, a renowned national law firm, took a decisive step against Regeneron Pharmaceuticals, Inc….

Read More

“Breaking News: Canadian Businessman Gets 41 Months in U.S. Prison for Hiding 450 BTC – Ouch!”

Canadian Businessman Receives 41-Month Sentence for Obstruction Businessman’s Account Blocked by Binance A Canadian businessman has been sentenced to 41 months in a U.S. federal prison after pleading guilty to obstruction of an official proceeding. The businessman, whose name has not been disclosed, had his account blocked by Binance, a popular cryptocurrency exchange platform. What…

Read More

“Breaking News: US SEC Acknowledges Bitwise’s XRP ETF Filing – A Surprising Move on Tuesday!”

The SEC’s Acknowledgement of Cboe BZX Exchange’s Filing to List Bitwise XRP ETF An Analysts’ Perspective on High Approval Chances Recently, the Securities and Exchange Commission (SEC) has acknowledged Cboe BZX Exchange’s filing to list Bitwise XRP ETF, a move that has sparked excitement and speculation in the cryptocurrency community. Analysts are predicting high approval…

Read More

Quaker Houghton Reveals Q4 and Full Year 2024 Earnings: A Peek Behind the Numbers

Quaker Houghton’s Q4’24 and Full Year 2024 Financial Results Quaker Houghton, a leading industrial process fluids company, recently announced its financial results for the fourth quarter and full year ending December 31, 2024. The company reported the following key figures: Q4’24 Financial Results: Net sales: $444.1 million Net income: $14.2 million Earnings per diluted share:…

Read More